Condition
Ocular Comfort
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
50%
2 of 4 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 4 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04693429Phase 1Completed
Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+
NCT04963543Not ApplicableCompletedPrimary
Evaluation of Comfort in Symptomatic Contact Lens Wearers
NCT01423773Not ApplicableCompletedPrimary
Ocular Comfort and OCT Observation of Post Lens Clearance and Ocular Tissue Compression
NCT00520260Phase 4Completed
Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
Showing all 4 trials